Skip to main content

Table 1 Main characteristics of the study population at inclusion (N = 368)

From: A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations

Parameter (N = 368)

Category

IDUs N (%)

nIDUs N (%)

Gender

Male

248/310 (80.0)

47/58 (81.1)

Nationality

Luxembourg

183/310 (59.0)

24/58 (41.4)

 

Portugal

60/310 (19.3)

13/58 (22.4)

Children at charge

Yes

54/310 (17.4)

9/58 (15.5)

Life time drug use

Heroin

279/279 (100.0)

28/28 (100.0)

 

Cocaine

280/310 (90.3)

37/58 (63.8)

 

Cannabis

286/334 (85.6)

48/334 (14.4)

 

Speedball

(heroin/cocaine combination)

205/310 (84.2)

0/58 (0.0)

Last 6 months IDU

Never borrowed used paraphernalia

162/256 (63.3)

 
 

Never lend used paraphernalia

161/255 (62.9)

 
 

Mostly shared: cups

69/94 (73.4)

 
 

Mostly shared: filters

68/94 (72.3)

 
 

Mostly shared: syringes

42/94 (44.6)

 

Last 6 months number of sexual partners (N = 266)

None

192/308 (62.3)

32/58 (55.2)

 

1-9

94/308 (30.5)

26/58 (44.8)

 

10+

22/308 (7.1)

0/58 (0)

Imprisonment (N = 366)

At least once during the last 10 years

215/308 (69.8)

31/58 (53.4)

Drug consumption in prison (N = 246)

Yes

130/215 (60.5)

8/31 (25.8)

Substitution treatment (N = 368)

Yes

286/310 (92.3)

19/58 (32.8))

Tattoo or piercing

None

87/309 (28.2)

28/58 (48.3)

 

Tattoo

100/309(32.4)

14/58 (24.1)

 

Piercing

23/309 (7.4)

9/58 (15.5)

 

Both

99/309 (32.0)

7/58 (12.1)

  1. Note: Denominators may vary because of missing answers to some questions.